Literature DB >> 6540777

The Chinese hamster ovary glycosylation mutants LEC11 and LEC12 express two novel GDP-fucose:N-acetylglucosaminide 3-alpha-L-fucosyltransferase enzymes.

C Campbell, P Stanley.   

Abstract

Evidence is presented that the GDP-fucose:N-acetyl-glucosaminide 3-alpha-L-fucosyltransferase activities of two Chinese hamster ovary glycosylation mutants, LEC11 and LEC12, are structurally distinct enzymes. The alpha(1,3)fucosyltransferase in LEC12 cell extracts binds to GDP-hexanolamine-Sepharose and is unaffected by 3 mM N-ethylmaleimide. In contrast, the alpha(1,3)fucosyltransferase activity in LEC11 cells does not bind readily to GDP-hexanolamine-Sepharose and is completely inhibited by 1 mM N-ethylmaleimide. The LEC11 and LEC12 alpha(1,3)fucosyltransferases also differ in the degree to which they are stimulated by divalent cations as well as in their abilities to fucosylate a variety of exogenous substrates. Of particular interest is the finding that the LEC11 alpha(1,3)fucosyltransferase adds fucose to certain sialylated glycoproteins, whereas the LEC12 enzyme is essentially unable to fucosylate these acceptors, although it is very active with their desialylated derivatives. The combined evidence shows that the LEC11 and LEC12 alpha(1,3)fucosyltransferase enzymes are different molecules and presumably, therefore, the products of distinct genes. In addition, neither of the enzymes appears identical to any of the previously described alpha(1,3)fucosyltransferase activities from other sources.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6540777

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Occurrence and specificities of alpha 3-fucosyltransferases.

Authors:  T de Vries; D H van den Eijnden
Journal:  Histochem J       Date:  1992-11

2.  Activation of two new alpha(1,3)fucosyltransferase activities in Chinese hamster ovary cells by 5-azacytidine.

Authors:  B Potvin; P Stanley
Journal:  Cell Regul       Date:  1991-12

3.  Normal cellular prion protein is a ligand of selectins: binding requires Le(X) but is inhibited by sLe(X).

Authors:  Chaoyang Li; Poki Wong; Tao Pan; Fan Xiao; Shaoman Yin; Binggong Chang; Shin-Chung Kang; James Ironside; Man-Sun Sy
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

4.  Purification of the N-acetylglucosaminide alpha(1-3/4)fucosyltransferase of human milk.

Authors:  S Eppenberger-Castori; H Lötscher; J Finne
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

5.  Tumor-related elevation of serum (alpha 1----3)-L-fucosyltransferase activity in gastric cancer.

Authors:  S Yazawa; T Asao; Y Nagamachi; S A Abbas; K L Matta
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

6.  Lectin activity as a marker for Hodgkin disease cells.

Authors:  E Paietta; R J Stockert; A G Morell; V Diehl; P H Wiernik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

7.  Chinese hamster ovary cell mutants with multiple glycosylation defects for production of glycoproteins with minimal carbohydrate heterogeneity.

Authors:  P Stanley
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

8.  CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x.

Authors:  M J Polley; M L Phillips; E Wayner; E Nudelman; A K Singhal; S Hakomori; J C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

9.  Expression of CD15 (FAL) on myeloid cells and chromosomal localization of the gene.

Authors:  P Tetteroo; A D Geurts van Kessel
Journal:  Histochem J       Date:  1992-11

10.  Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function.

Authors:  Oliver Popp; Samuel Moser; Jörg Zielonka; Petra Rüger; Silke Hansen; Oliver Plöttner
Journal:  MAbs       Date:  2017-12-12       Impact factor: 5.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.